ATE234283T1 - Indolecarbonsäurederivate und ihre verwendung als arzneimittel - Google Patents

Indolecarbonsäurederivate und ihre verwendung als arzneimittel

Info

Publication number
ATE234283T1
ATE234283T1 AT98942786T AT98942786T ATE234283T1 AT E234283 T1 ATE234283 T1 AT E234283T1 AT 98942786 T AT98942786 T AT 98942786T AT 98942786 T AT98942786 T AT 98942786T AT E234283 T1 ATE234283 T1 AT E234283T1
Authority
AT
Austria
Prior art keywords
acid derivatives
medicinal products
alkyl
indolecarboxylic acid
chr3r4
Prior art date
Application number
AT98942786T
Other languages
English (en)
Inventor
Bruno Bernard
Catherine Gerst
Jean-Baptiste Galey
Maria Dalko
Patrick Pichaud
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE234283T1 publication Critical patent/ATE234283T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98942786T 1997-09-05 1998-08-26 Indolecarbonsäurederivate und ihre verwendung als arzneimittel ATE234283T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9711076A FR2768146B1 (fr) 1997-09-05 1997-09-05 Nouveaux composes de la famille des indole-carboxyliques et leur utilisation
PCT/FR1998/001853 WO1999012905A1 (fr) 1997-09-05 1998-08-26 Composes indole-carboxyliques et leur utilisation comme composes pharmaceutiques

Publications (1)

Publication Number Publication Date
ATE234283T1 true ATE234283T1 (de) 2003-03-15

Family

ID=9510808

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03000188T ATE334962T1 (de) 1997-09-05 1998-08-26 Indolecarbonsäurederivate und ihre verwendung als arzneimittel
AT98942786T ATE234283T1 (de) 1997-09-05 1998-08-26 Indolecarbonsäurederivate und ihre verwendung als arzneimittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03000188T ATE334962T1 (de) 1997-09-05 1998-08-26 Indolecarbonsäurederivate und ihre verwendung als arzneimittel

Country Status (10)

Country Link
US (2) US6448285B1 (de)
EP (2) EP0964852B1 (de)
JP (2) JP4090515B2 (de)
AT (2) ATE334962T1 (de)
AU (1) AU9079198A (de)
CA (2) CA2569685A1 (de)
DE (2) DE69812073T2 (de)
ES (2) ES2268169T3 (de)
FR (1) FR2768146B1 (de)
WO (1) WO1999012905A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495538B2 (en) * 1999-06-23 2002-12-17 Zinc Therapeutics, Canada Inc. Zinc ionophores as therapeutic agents
FR2796274B1 (fr) 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2796279B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
AU2002357003A1 (en) * 2001-12-28 2003-07-24 Guilford Pharmaceuticals Inc. Indoles as naaladase inhibitors
WO2003082271A2 (en) 2002-04-03 2003-10-09 Astrazeneca Ab Indole derivatives having anti-angiogenetic activity
US7041636B1 (en) 2004-01-22 2006-05-09 Benton Melody M Composition for counteracting hair loss
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
US20080063673A1 (en) * 2006-09-13 2008-03-13 Akridge Robert E Method and kit for treatment/prevention of hair loss
US20080160509A1 (en) * 2006-09-13 2008-07-03 Pacific Bioscience Laboratories, Inc. Assays for predicting and assessing predisposition to male pattern baldness
WO2008042571A2 (en) * 2006-09-29 2008-04-10 Smithkline Beecham Corporation Substituted indole compounds
MX2009006880A (es) 2006-12-22 2009-07-03 Schering Corp Derivados indolicos con anillo unido en las posiciones 4,5 para tratar o prevenir infecciones virales por virus de la hepatitis c e infecciones virales relacionadas.
CA2674831A1 (en) 2006-12-22 2008-11-13 Schering Corporation 5,6-ring annulated indole derivatives and methods of use thereof
JP5211068B2 (ja) * 2006-12-22 2013-06-12 メルク・シャープ・アンド・ドーム・コーポレーション Hcvおよび関連するウイルス疾患の治療または予防のための4,5−環インドール誘導体
KR20090001013A (ko) * 2007-06-29 2009-01-08 주식회사 웰스킨 인돌-3-알킬카복실산을 함유하는 여드름 치료제 및 피지분비 억제제, 및 이를 포함하는 광역학적 치료용 키트
CA2697500A1 (en) 2007-08-29 2009-03-12 Schering Corporation 2,3-substituted azaindole derivatives for treating viral infections
EP2197842B1 (de) 2007-08-29 2012-05-23 Schering Corporation 2,3-substituierte indolderivate zur behandlung von virusinfektionen
ES2447543T3 (es) 2007-08-29 2014-03-12 Merck Sharp & Dohme Corp. Derivados de indol sustituidos y métodos de utilización de los mismos
CA2705586A1 (en) 2007-11-16 2009-05-22 Schering Corporation 3-heterocyclic substituted indole derivatives and methods of use thereof
EP2222672B1 (de) 2007-11-16 2013-12-18 Merck Sharp & Dohme Corp. 3-aminosulfonylsubstituierte indolderivate und verfahren zu deren anwendung
WO2009152200A1 (en) 2008-06-13 2009-12-17 Schering Corporation Tricyclic indole derivatives and methods of use thereof
WO2010143803A2 (en) * 2009-06-08 2010-12-16 Industry Foundation Of Chonnam National University New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same
FR2953722B1 (fr) 2009-12-16 2012-03-09 Expanscience Lab Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
KR101213495B1 (ko) * 2010-06-03 2013-01-14 삼성디스플레이 주식회사 유기 발광 소자
JP6910027B2 (ja) * 2017-03-29 2021-07-28 株式会社コーセー チロシナーゼ活性阻害剤、メラニン産生抑制剤及び美白剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB359876A (en) 1930-05-20 1931-10-29 British Thomson Houston Co Ltd Improvements in and relating to polyphase thermionic generators
BE794483A (fr) * 1972-01-26 1973-07-24 Boehringer Mannheim Gmbh Derives de l'acide indol-carbonique a effet hypoglycemiant et procedes pour leur preparation
LU86347A1 (fr) * 1986-03-06 1987-11-11 Oreal Compositions pour la coloration de la peau a base de derives d'indole
FR2686345A1 (fr) * 1992-01-16 1993-07-23 Oreal Produit a base de particules minerales colorees comportant un pigment melanique, son procede de preparation et son utilisation en cosmetique.
FR2689898B1 (fr) * 1992-04-08 1994-06-10 Oreal Pigments comportant un support inorganique et le produit de reaction d'un derive indolique et d'un derive quinonique, leur procede de preparation et leur utilisation en cosmetique.
EP0648208A1 (de) * 1993-04-05 1995-04-19 Fujisawa Pharmaceutical Co., Ltd. Indol derivate als restosteron 5 alpha-reductase inhibitoren
DE4314317A1 (de) 1993-04-30 1994-11-03 Henkel Kgaa Isatinhaltige Mittel zum Färben von keratinhaltigen Fasern
WO1997035572A1 (en) * 1996-03-28 1997-10-02 Smithkline Beecham Corporation Carboxylic acid indole inhibitors of chemokines
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
JP4090515B2 (ja) 2008-05-28
CA2271085A1 (fr) 1999-03-18
ATE334962T1 (de) 2006-08-15
DE69835460D1 (de) 2006-09-14
FR2768146A1 (fr) 1999-03-12
EP0964852A1 (de) 1999-12-22
DE69835460T2 (de) 2007-07-26
DE69812073D1 (de) 2003-04-17
US20030050325A1 (en) 2003-03-13
FR2768146B1 (fr) 2000-05-05
US6448285B1 (en) 2002-09-10
DE69812073T2 (de) 2003-09-25
JP2004035566A (ja) 2004-02-05
CA2271085C (fr) 2007-04-17
ES2268169T3 (es) 2007-03-16
US6596753B2 (en) 2003-07-22
AU9079198A (en) 1999-03-29
EP1302460B1 (de) 2006-08-02
EP0964852B1 (de) 2003-03-12
JP2000508352A (ja) 2000-07-04
EP1302460A1 (de) 2003-04-16
ES2195382T3 (es) 2003-12-01
CA2569685A1 (fr) 1999-03-18
WO1999012905A1 (fr) 1999-03-18

Similar Documents

Publication Publication Date Title
ATE334962T1 (de) Indolecarbonsäurederivate und ihre verwendung als arzneimittel
ATE133945T1 (de) 3,5-di-tertiärbutyl-4- hydroxyphenylmethylenderivate von 2- substituierten thiazolidinonen, oxazolidinonen und imidazolidinonen als antientzündlich wirkende mittel
ATE73797T1 (de) Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel.
EE03139B1 (et) Piperasiiniderivaadid, nende kasutamine ja farmatseutiline kompositsioon
FR2687543B1 (fr) Utilisation de derives du triazole pour la protection du bois.
ATE125808T1 (de) Indolederivate und ihre verwendung als serotonin- antagoniste.
ATE9474T1 (de) Cephalosporinverbindungen und ihre herstellung.
ATE421524T1 (de) 5-ring-heterocyclen, ihre herstellung, ihre verwendung als inhibitoren der leukozytenadhäsion und sie enthaltende pharmazeutische präparate
CO4970719A1 (es) Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
ATE172193T1 (de) Piperazinderivate
DK0615971T3 (da) 5-(Piperazinylalkyl)-1,5-benzothiazepinoner, der kan anvendes som calciumantagonister
NO981814D0 (no) Nye heterocykliske forbindelser, fremgangsmÕte ved deres fremstilling og farmas÷ytiske sammensetninger som inneholder dem
ATE219065T1 (de) Arylpiperidin- und arylpiperazin-derivate und sie enthaltende arzneimittel
PL352172A1 (en) Derivatives of n-alkoxyalkylo-n,n-dialkyloamine or salts thereof and the agents containing these compounds used in treatment of neurodegenerative diseases
NO893039L (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
NO963854D0 (no) Okulart spenningsnedsettende middel
ATE69802T1 (de) Ungesaettigte derivate von methylendianilin.
ATE58536T1 (de) 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
DK0731091T3 (da) 2-oxoindolin-derivater som cholecystokininreceptor-antagonister
FI103726B1 (fi) Karbapeneemiantibioottien valmistuksessa välituotteina käyttökelpoiset S-2-karbamoyyli- ja tiokarbamoyylifenyyli-2(R)- (3S,4S) -3-[1(R)-trialkyylisilyylioksi)etyyli]-2-okso-4-atsetidinyyli propionaatti ja -tiopropionaattijohdannaiset ja menetelmät niiden valmistamiseksi
WO1999055156A3 (de) Verwendung von derivaten des iminotriazols als pflanzenschutzmittel und neue iminotriazole

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties